Clinical Trials Logo

Rabies Virus Infection clinical trials

View clinical trials related to Rabies Virus Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT05832073 Not yet recruiting - Clinical trials for Rabies Virus Infection

Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Start date: April 30, 2023
Phase: Early Phase 1
Study type: Interventional

rabies mab CBB 1 is mainly used for passive immunization of patients bitten or scratched by rabies or other animals carrying rabies virus, this study mainly studies the safety, tolerability, pharmacokinetics, neutralizing antibody activity and immunogenic characteristics of rabies mAb CBB 1 in healthy adults

NCT ID: NCT05382650 Recruiting - Pediatrics Clinical Trials

Survey of Human Rabies Immune Globulin Safety in Children

Start date: February 22, 2023
Phase:
Study type: Observational

This observational study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED), and up to 4 additional sites in the United States. The safety of human rabies immune globulin (HRIG) 300 IU/mL product (HyperRAB®) in pediatric patients has not been fully established. The purpose of this study is to evaluate the safety of HRIG 300 IU/mL when given to pediatric patients per standard of care for rabies postexposure prophylaxis (PEP) in the ED.

NCT ID: NCT04213950 Completed - Rabies Clinical Trials

Improving Adherence to Rabies PEP Guideline Recommendations

Start date: December 29, 2019
Phase: N/A
Study type: Interventional

This quasi-experimental, quality improvement study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED). Previous research identified opportunities to improve patient selection and delivery of rabies immune globulin (IG) as recommended by Centers for Disease Control and Prevention (CDC) guideline recommendations for rabies postexposure prophylaxis (PEP). The purpose of this study is to develop, implement, and measure the impact of a quality improvement bundle that consists of (1) rabies PEP electronic health records (EHR) enhancements, (2) education to ED staff, and (3) education to patients. Adherence to quality indicators, which are based on CDC guideline recommendations, for patient selection and delivery of rabies IG for 12 months following implementation (post-implementation group) will be compared with a historical control group.